Showing results (91-100 of 109) with videos related to
Sort By:
Pageof 11
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 17, 2003
Coxsackievirus and adenovirus receptor, a tight junction membrane protein, is expressed in glomerular podocytes in the kidneyMaki Nagai, Eishin Yaoita, Yutaka Yoshida, et al.Biochemical and Biophysical Research Communications|January 3, 2012
Critical importance of the de novo pyrimidine biosynthesis pathway for Trypanosoma cruzi growth in the mammalian host cell cytoplasmMuneaki Hashimoto, Jorge Morales, Yoshihisa Fukai, et al.Pathology International|January 22, 2005
Uninephrectomy induces progressive glomerulosclerosis and apoptosis in anti-Thy1 glomerulonephritisNobuko Sakai, Ken Iseki, Shigeo Suzuki, et al.Influenza and Other Respiratory Viruses|January 12, 2025
Temporal Trends in Respiratory Infection Epidemics Among Pediatric Inpatients Throughout the Course of the COVID-19 Pandemic From 2018 to 2023 in Fukushima Prefecture, JapanYohei Kume, Koichi Hashimoto, Hisao Okabe, et al.Journal of Medical Microbiology|May 12, 2026
Temporal genetic changes in human bocavirus 1 in Fukushima, Japan, from 2018 to 2024Tatsuya Shirai, Miyuki Kawase, Satoko Sugimoto, et al.Microbiology Resource Announcements|January 20, 2022
Thirteen Nearly Complete Genome Sequences of Human Bocavirus 1 Isolated from Pediatric Inpatients in Fukushima, JapanMasatoshi Kakizaki, Yohei Kume, Reiko Suwa, et al.Influenza and Other Respiratory Viruses|April 30, 2022
Changes in virus detection in hospitalized children before and after the severe acute respiratory syndrome coronavirus 2 pandemicYohei Kume, Koichi Hashimoto, Mina Chishiki, et al.Microbiology Resource Announcements|July 21, 2022
Nearly Complete Genome Sequences of 12 Types of Human Rhinoviruses Isolated from Pediatric Inpatients in Fukushima, JapanKazutaka Egawa, Masatoshi Kakizaki, Yohei Kume, et al.Japanese Journal of Infectious Diseases|January 3, 2024
Molecular Epidemiology of Human Metapneumovirus in East Japan before and after COVID-19, 2017-2022Kazuya Shirato, Reiko Suwa, Naganori Nao, et al.Oncotarget|April 24, 2018
Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinomaYoshiaki Yamamoto, Ryouichi Tsunedomi, Yusuke Fujita, et al.Pageof 11